It looks to me that Kimberly Clark (UK) are targeting the $3B transdermal patch market using imprint technology in a new development program with imprint supplier – Obducat (Sweden). Kimberly-Clark is ...
Nutriband files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for abuse.
DUBLIN--(BUSINESS WIRE)--The "Global Transdermal Patches Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering. The global transdermal patches market is ...
Although antigen-specific autoimmunity is thought to play a critical role in the pathogenesis of multiple sclerosis, all currently available therapies reduce global immune function without targeting ...
Noven Submits New Drug Application for Investigational Dextroamphetamine Transdermal System for ADHD
MIAMI & JERSEY CITY, N.J.--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc., (“Noven”) a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today confirmed it has submitted a New Drug ...
Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. Eight years ago, I wrote about a startup trying to deliver cancer ...
Daytrana (methylphenidate) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). It comes as a transdermal patch that’s usually applied to the skin once per day.
Minimize reactions to transdermal patches Applying triamcinolone prior to a transdermal patch helps prevent contact dermatitis. If a patient has a mild reaction to the adhesive on a transdermal patch, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results